Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’ – (Eye 30, 766 (May 2016))

12 May 2016

This news item is available to RCOphth members only, please log in below to access.